ID30377A - Metoda pengobatan neurodegenerasi - Google Patents

Metoda pengobatan neurodegenerasi

Info

Publication number
ID30377A
ID30377A IDW00200102283A ID20012283A ID30377A ID 30377 A ID30377 A ID 30377A ID W00200102283 A IDW00200102283 A ID W00200102283A ID 20012283 A ID20012283 A ID 20012283A ID 30377 A ID30377 A ID 30377A
Authority
ID
Indonesia
Prior art keywords
treatment method
neurodegeneration
neurodegeneration treatment
treatment
Prior art date
Application number
IDW00200102283A
Other languages
English (en)
Indonesian (id)
Inventor
Eiichi Otomo
Yoshiyuki Takasu
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of ID30377A publication Critical patent/ID30377A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IDW00200102283A 2000-02-23 2001-02-23 Metoda pengobatan neurodegenerasi ID30377A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51195200A 2000-02-23 2000-02-23

Publications (1)

Publication Number Publication Date
ID30377A true ID30377A (id) 2001-11-29

Family

ID=24037094

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200102283A ID30377A (id) 2000-02-23 2001-02-23 Metoda pengobatan neurodegenerasi

Country Status (20)

Country Link
US (2) US6423739B1 (cs)
EP (1) EP1171123B1 (cs)
JP (1) JP2003523385A (cs)
KR (1) KR20010110798A (cs)
CN (1) CN1362877A (cs)
AR (1) AR030551A1 (cs)
AT (1) ATE336246T1 (cs)
AU (1) AU784418B2 (cs)
BR (1) BR0104586A (cs)
CA (1) CA2368352C (cs)
DE (1) DE60122252T2 (cs)
DK (1) DK1171123T3 (cs)
ES (1) ES2270981T3 (cs)
HK (1) HK1047038A1 (cs)
ID (1) ID30377A (cs)
IL (1) IL145799A (cs)
MX (1) MXPA01010749A (cs)
NO (1) NO321911B1 (cs)
TW (1) TWI289060B (cs)
WO (1) WO2001062246A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077709A1 (en) * 1999-05-31 2004-04-22 Daiichi Pharmaceutical Co., Ltd. Neuronal death inhibitors
US7608636B2 (en) * 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
ATE404192T1 (de) * 2001-08-22 2008-08-15 Hamilton Pharmaceuticals Inc Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
US20060241144A1 (en) * 2005-04-20 2006-10-26 Albert Cha Method for treating apathy syndrome
EP2490685B1 (en) 2009-10-22 2017-12-13 University College Dublin National University Of Ireland, Dublin Causal therapy of diseases or conditions associated with cns or pns demyelination
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469995A (en) * 1946-07-23 1949-05-10 Schaul Martin Carl Process for the production of food preparations from potatoes and similar farinaceoustubers
US3031314A (en) * 1960-03-16 1962-04-24 Carl E Hendel Preparation of dehydrated potatoes
US3260607A (en) * 1961-02-07 1966-07-12 Canadian Patents Dev Preparation of dehydrated cooked mashed potato
US3968265A (en) * 1973-02-01 1976-07-06 American Potato Company Freeze-thaw stable, french fry potato product and process for producing the same
DE2924011C2 (de) 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
IT1141287B (it) 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
DE2923975A1 (de) 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
SK279285B6 (sk) 1991-05-02 1998-09-09 Daiichi Pharmaceutical Co. Použitie n-(2,6-dimetylfenyl)-2-(2-oxo-1-pyrolidin
US5525058A (en) 1992-03-27 1996-06-11 American Dental Technologies, Inc. Dental treatment system
DE69519635T2 (de) 1995-07-10 2001-05-31 Kodera Electronics Co., Ltd. Vorrichtung zum einbringen eines zu bearbeitenden drahtes
US6107330A (en) 1995-08-07 2000-08-22 Daiichi Pharmaceutical Co., Ltd. Inhibitor for narcotic analgesic dependence/resistance acquisition
JP2002241272A (ja) 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
ATE226017T1 (de) 1996-07-30 2002-11-15 Ecolab Gmbh & Co Ohg Filmbildendes mittel zum schutz vor infektionen
WO1998014213A1 (fr) 1996-10-01 1998-04-09 Daiichi Pharmaceutical Co., Ltd. Stabilisateur de la membrane mitochondriale
US6211701B1 (en) 1996-12-16 2001-04-03 Rose Research, Llc Low power line switching circuit, device and method
IT1293533B1 (it) 1997-07-14 1999-03-01 Angeletti P Ist Richerche Bio Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che
ATE266401T1 (de) 1997-07-15 2004-05-15 Daiichi Seiyaku Co Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund
JPH1180027A (ja) 1997-09-12 1999-03-23 Dai Ichi Seiyaku Co Ltd 向知性薬
TW544311B (en) 1998-08-06 2003-08-01 Daiichi Seiyaku Co Therapeutic or preventive agent for intractable epilepsies
EP1180366A1 (en) 1999-05-31 2002-02-20 Daiichi Pharmaceutical Co., Ltd. Neuronal death inhibitors

Also Published As

Publication number Publication date
ES2270981T3 (es) 2007-04-16
TWI289060B (en) 2007-11-01
NO321911B1 (no) 2006-07-17
US20010051653A1 (en) 2001-12-13
HK1047038A1 (zh) 2003-02-07
EP1171123A1 (en) 2002-01-16
MXPA01010749A (es) 2002-08-20
IL145799A0 (en) 2002-07-25
DE60122252D1 (de) 2006-09-28
US6399650B2 (en) 2002-06-04
CA2368352A1 (en) 2001-08-30
IL145799A (en) 2006-10-31
ATE336246T1 (de) 2006-09-15
US20020055534A1 (en) 2002-05-09
DE60122252T2 (de) 2007-07-05
BR0104586A (pt) 2002-01-08
NO20015162L (no) 2001-12-21
CA2368352C (en) 2009-11-10
WO2001062246A1 (en) 2001-08-30
CN1362877A (zh) 2002-08-07
KR20010110798A (ko) 2001-12-13
US6423739B1 (en) 2002-07-23
EP1171123B1 (en) 2006-08-16
AU3414501A (en) 2001-09-03
NO20015162D0 (no) 2001-10-22
JP2003523385A (ja) 2003-08-05
AR030551A1 (es) 2003-08-27
DK1171123T3 (da) 2006-12-04
AU784418B2 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
DK1267650T3 (da) Tobakbehandling
DE60028849D1 (de) Sterilisationsmethode
DE60117286D1 (de) Prozesssteuerung
DE60120276D1 (de) Laserbehandlungsgerät
DE60105229D1 (de) Laserbehandlungsgerät
NL1014915A1 (nl) Nieuwe behandelingsmethode.
DE60029553D1 (de) Schätzungsmethode
DE60121531D1 (de) Laserbehandlungsgerät
DE60137595D1 (de) Bilderzeugungsverfahren
DE60103427D1 (de) Übereinstimmungssteuerverfahren
DE60100737D1 (de) Laserbehandlungsgerät
NO20032122L (no) Forbedret behandling
ATE502118T1 (de) Amplifizierungsverfahren
DK1281616T3 (da) Væskepåfyldningsmetode
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
FI20002466A0 (fi) Tunnistusmenetelmä
PT102870A (pt) Metodo de tratamento de condensados
DE60140597D1 (de) Vakuumbehandlungsverfahren
ID30377A (id) Metoda pengobatan neurodegenerasi
NO20032563D0 (no) Filtreringsfremgangsmåte
GB0026838D0 (en) Treatment method
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE50107729D1 (de) Regelverfahren
NO20022643D0 (no) Reduksjonsprosess
ES1045721Y (es) Aparato de electromedicina